The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
April 15th 2025
A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.
Mike Payne Discusses Omada Health's Prevent Program
October 19th 2016Omada Health’s Prevent program has enrolled nearly 55,000 patients since its start in 2012, and has been demonstrating successful, real-world applicable results for patients with pre-diabetes, said Mike Payne, MBA, MSci, chief healthcare development officer at Omada Health.
Watch
High-Doses of Antidepressants Less Risky on Heart Than Initially Thought
October 18th 2016High doses of the antidepressants citalopram (Celexa) and escitalopram (Cipralex, Lexapro) do not appear to carry greater risk of sudden cardiac death than comparable doses of other selective serotonin reuptake inhibitors, according to a new study.
Read More
Pepsi Announces Plan to Cut Sugar, Salt, Fat From Food and Soda Products
October 17th 2016The initiative comes as consumers move away from soda toward healthier beverages. Pepsi, in particular, has seen declining sales, and voters in several US cities will decide on soda taxes on November 8, 2016.
Read More
Dr Scott Breidbart Discusses the Impacts of Patient Behavior on Diabetes Care
October 16th 2016A patient may be aware of the complications that could arise from a lack of adherence with a chronic disease like diabetes, but education is not enough to change a patient’s lifestyle, explained Scott Breidbart, MD, MBA, chief clinical officer of EmblemHealth.
Watch
This Week in Managed Care: October 14, 2016
October 14th 2016This week, the top stories in managed care included HHS releasing the final rule for the Medicare Access and CHIP Reauthorization Act, a commentary on the downside of drug coupons, and the World Health Organization called on countries to enact a soda tax.
Watch
Children, Teens With Autism More Likely to Be Obese
October 12th 2016A study from Tufts University School of Medicine found that at age 10, obesity rates among children on the autism spectrum are not that much higher than children outside the spectrum, but rates diverge sharply as children get older.
Read More
Kristen McGovern on Cost Concerns and the Increasing Use of Telehealth
October 10th 2016Despite concerns, the use of telehealth visits does not have a significant impact on the overall budget, explained Kristen McGovern, JD, partner at Sirona Strategies. In fact, a recent study found that using telehealth services decreased costs over the long term.
Watch
Global Life Expectancy Rises, but 70% of Deaths Due to Noncommunicable Diseases
October 7th 2016Health is improving around the world, but 7 out of 10 deaths are now due to noncommunicable diseases, like stroke, diabetes, chronic kidney disease, and drug use disorders, according to a special issue of The Lancet.
Read More
This Week in Managed Care: October 7, 2016
October 7th 2016This week, the top managed care stories included conference coverage from the Academy of Managed Care Pharmacy's 2016 Nexus, Bill Clinton courted controversy when discussing the Affordable Care Act, and research finds fear of a job loss can increase the risk of diabetes.
Watch
Does Online Testing Overdiagnose Prediabetes?
October 7th 2016A short online test evaluates respondents’ health status to determine their risk of having prediabetes. However, some doctors worry that too many people will fall into the high-risk category, contributing to an overuse of resources.
Read More
FDA Approves Medtronic's MiniMed 670G, 1st Hybrid Closed Loop System
September 28th 2016The company's announcement notably does not use the term "artificial pancreas," although the technology is a considerably more significant advance from the 530G threshold suspend device of 2013. When the description "artificial pancreas" was attached to that product, the term was met with howls of protest from the type 1 diabetes community.
Read More
Therapeutics Issue of Evidence-Based Diabetes Management Takes on Cost, Coverage, and Combinations
September 27th 2016Whether it’s the high cost of insulin or the question of when to start combination therapy, the new issue of Evidence-Based Diabetes Management, a publication of The American Journal of Managed Care, covers up-to-the-minute topics in this special issue on therapeutics. Editor-in-chief Robert A. Gabbay, MD, PhD, FACP, leads off this issue featuring voices of providers, pharmaceutical leaders, payers, and patients.
Read More